| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.22 | 5e-05 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.009 |